Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2015 / Cilt: 48 - Sayı: 3

DOES MEAN PLATELET VOLUME HAVE A ROLE IN METABOLIC SYNDROME GAMES?

METABOLİK SENDROM OYUNLARINDA ORTALAMA TROMBOSİT HACMİNİN ROLÜ VAR MIDIR?

Pages
124–132
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We may say that as metabolic syndrome components are concerned the presence of hypertension, obesity and diabetes mellitus constitute an increase in mean platelet volumes, suggesting that platelet activity may have a relation with those cardiovascular risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: The association between platelet activity and diabetes, hypertension, obesity and dyslipemia has been uncertain.
📊
Key Findings & Data:The mean platelet volume levels had positive correlation with hypertension, obesity, diabetes mellitus, body mass index and waist circumference in patients with MS, but there was not any correlation with dyslipemia, age, gender and Hemoglobin A1c.
💡
Conclusion & Impact:We may say that as metabolic syndrome components are concerned the presence of hypertension, obesity and diabetes mellitus constitute an increase in mean platelet volumes, suggesting that platelet activity may have a relation with those cardiovascular risk factors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: The association between platelet activity and diabetes, hypertension, obesity and dyslipemia has been uncertain. We wanted to investigate the association of mean platelet volume with metabolic syndrome.MATERIAL AND METHODS: Mean platelet volume levels were investigated in healthy participants and patients with metabolic syndrome and antropometric and demographic parameters were compared. We also seeked correlation of mean platelet volume with metabolic syndrome components and also age and gender.RESULTS: Mean platelet volume levels were higher in patients with metabolic syndrome than in normals. The mean platelet volume levels had positive correlation with hypertension, obesity, diabetes mellitus, body mass index and waist circumference in patients with MS, but there was not any correlation with dyslipemia, age, gender and Hemoglobin A1c. CONCLUSIONS: Mean platelet volume is associated with metabolic syndrome. We may say that as metabolic syndrome components are concerned the presence of hypertension, obesity and diabetes mellitus constitute an increase in mean platelet volumes, suggesting that platelet activity may have a relation with those cardiovascular risk factors.

Özet

AMAÇ: Trombosit aktivitesi ile diyabetes, hipertansiyon, obezite ve dislipemi bağlantısı halen açık değildir. Ortalama trombosit hacmi ve metabolik sendrom ilişkisini araştırmak istedik. GEREÇ VE YÖNTEMLER: Ortalama trombosit hacmi sağlıklı kişilerde ve metabolik sendromlu hastalarda araştırıldı ve antropolojik ve demografik parametreler kıyaslandı. Ayrıca ortalama trombosit hacmi ile metabolik sendrom componentleri, yaş ve cinsiyet arasında korelasyonu araştırdık.BULGULAR: Ortalama trombosit hacmi metabolik sendromu olan hastalarda normallerden yüksek saptandı. Metabolik sendromlu hastalarda ortalama trombosit hacmi seviyeleri hipertansiyon, obezite, diabetes mellitus, vucut kitle indeksi ve bel çevresi ile pozitif korelasyon gösterdi ama dislipemi, yaş, cinsiyet ve Hemoglobin A1c arasında korelasyon bulunmadı.SONUÇ: Ortalama trombosit hacmi metabolik sendrom ile ilişkilidir. Diyebiliriz ki metabolik sendrom komponentleri söz konusu olduğunda hipertansiyon, obezite ve diyabetes mellitus ile ortalama trombosit hacmi artışı ilişkilidir. Bu bize platelet aktivitesi ile belirtilen kardiyovasküler risk faktörleri arasında bir bağlantı olduğunu düşündürmektedir.

🔖

Cite This Article

ATALAY, E., BAYRAM, M., GÜRSOY, G., ALKAN, S., DAL, H. C. (2022). DOES MEAN PLATELET VOLUME HAVE A ROLE IN METABOLIC SYNDROME GAMES?. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 48 - Sayı: 3, 124–132. https://ajindex.com/articles/441406

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. A1berti KG, Zimmet P, Shaw I. IDF epidemiology task force consensus group. The metabolic syndrome: new worldwide definition. Lancet 2005
  2. 366(9491):1059-62. 2)Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med. 2003
  3. O]ijhoek IK, Van Der GraafY, Banga I-D et a]. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral artery disease or abdominal aortic aneurysm. European Heart I. 2004
  4. Nationa1 Cholesterol Education Program. Detection, evaluation and treatment of high blood cholesterol in adults. Circulation. 2002
  5. Mancia G, De Backer Dominiczak et a1. Management of arterial hypertension of the European Society of Hypertension, European Society of Cardiology, 2007 guidelines for the management of arterial hypertension. Hypertens. 2007
  6. World Health Organisation. Obesity: Preventing and managing the Global epidemic. Geneva. The World Health Organisation
  7. Technical Report Series no 894. 2000
  8. i-Xii, 1-253. 7)Bennett PH. The diagnosis of diabetes: new international classification and diagnostic criteria. Annu Rev Med. 1983
  9. Grundy SM, Cleeman II, Daniels SR et al. Diagnosis and management of the metabolic syndrome:An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-52. 9)Demirin H, Ozhan H, chun et al. Normal range of mean platelet volume in healthy subjects: Insight from large epidemiologic study. Thromb Res. 2011
  10. Descroches S, Lamarche B. The evolving definitions and in cresing prevalence of the metabolic syndroe. Applied physiology, Nutrition and Metabolism. 2007
  11. Koloou GD, Anagnostopoulou KK, Salpea KD et al. The prevalence of the metabolic syndrome in various populations. The American Iournal of the Medical Sciences. 2007
  12. Kozan A, Oğuz A, Abacı et al. Prevalence of the metabolic syndrome among Turkish adults. Eur Clin Nutr. 2007
  13. Kamath S, Blann AD, Lip GY Platelet activation: assessment and quantification. Eur Heart I. 2001
  14. Martin IF, Trowbridge EA, Salmon et al. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2, production and megakaryocyte nuclear DNA concentration. Thrombosis Research. 1983
  15. Esposito K, Nappo F, Marfella et al.